• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AUA 指南:间质性膀胱炎/膀胱疼痛综合征的诊断与治疗。

AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

机构信息

American Urological Association Education and Research, Inc., Linthicum, Maryland, USA.

出版信息

J Urol. 2011 Jun;185(6):2162-70. doi: 10.1016/j.juro.2011.03.064. Epub 2011 Apr 16.

DOI:10.1016/j.juro.2011.03.064
PMID:21497847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9341322/
Abstract

PURPOSE

To provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

MATERIALS AND METHODS

A systematic review of the literature using the MEDLINE® database (search dates 1/1/83-7/22/09) was conducted to identify peer reviewed publications relevant to the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Insufficient evidence-based data were retrieved regarding diagnosis and, therefore, this portion of the Guideline is based on Clinical Principles and Expert Opinion statements. The review yielded an evidence base of 86 treatment articles after application of inclusion/exclusion criteria. These publications were used to create the majority of the treatment portion of the Guideline. When sufficient evidence existed, the body of evidence for a particular treatment was assigned a strength rating of A (high), B (moderate) or C (low). Additional treatment information is provided as Clinical Principles and Expert Opinion when insufficient evidence existed. See text and algorithm for definitions, and detailed diagnostic management, and treatment frameworks.

RESULTS

The evidence-based guideline statements are provided for diagnosis and overall management of interstitial cystitis/bladder pain syndrome as well as for various treatments. The panel identified first through sixth line treatments as well as developed guideline statements on treatments that should not be offered.

CONCLUSIONS

Interstitial cystitis/bladder pain syndrome is best identified and managed through use of a logical algorithm such as is presented in this Guideline. In the algorithm the panel identifies an overall management strategy for the interstitial cystitis/bladder pain syndrome patient. Diagnosis and treatment methodologies can be expected to change as the evidence base grows in the future.

摘要

目的

为间质性膀胱炎/膀胱疼痛综合征的诊断和治疗提供临床框架。

材料和方法

使用 MEDLINE®数据库(搜索日期为 1983 年 1 月 1 日至 2009 年 7 月 22 日)进行了系统的文献复习,以确定与间质性膀胱炎/膀胱疼痛综合征的诊断和治疗相关的同行评议出版物。关于诊断,检索到的循证数据不足,因此本指南的这一部分基于临床原则和专家意见声明。应用纳入/排除标准后,该综述得出了 86 篇治疗文章的证据基础。这些出版物被用于创建指南治疗部分的大部分内容。当存在足够的证据时,特定治疗的证据体被分配为 A(高)、B(中)或 C(低)强度等级。当证据不足时,提供了更多的治疗信息,作为临床原则和专家意见。请参阅文本和算法,了解定义、详细的诊断管理和治疗框架。

结果

提供了基于证据的指南声明,用于间质性膀胱炎/膀胱疼痛综合征的诊断和整体管理,以及各种治疗方法。该小组确定了一线至六线治疗方法,并制定了不应提供的治疗方法的指南声明。

结论

通过使用本指南中提出的逻辑算法,最好识别和管理间质性膀胱炎/膀胱疼痛综合征。在该算法中,小组为间质性膀胱炎/膀胱疼痛综合征患者确定了整体管理策略。随着未来证据基础的增长,诊断和治疗方法预计会发生变化。

相似文献

1
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.AUA 指南:间质性膀胱炎/膀胱疼痛综合征的诊断与治疗。
J Urol. 2011 Jun;185(6):2162-70. doi: 10.1016/j.juro.2011.03.064. Epub 2011 Apr 16.
2
Intravesical treatments for painful bladder syndrome/ interstitial cystitis.用于疼痛性膀胱综合征/间质性膀胱炎的膀胱内治疗。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD006113. doi: 10.1002/14651858.CD006113.pub2.
3
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
4
Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.治疗膀胱疼痛综合征患者症状的干预措施:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jul 30;7(7):CD013325. doi: 10.1002/14651858.CD013325.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
7
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.用于血尿调查的诊断测试和算法:系统评价与经济评估
Health Technol Assess. 2006 Jun;10(18):iii-iv, xi-259. doi: 10.3310/hta10180.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.

引用本文的文献

1
Updates in pelvic neuromodulation: the role of pelvic neuromodulation in pelvic disorders.盆腔神经调节的进展:盆腔神经调节在盆腔疾病中的作用
Front Urol. 2024 Mar 15;4:1329305. doi: 10.3389/fruro.2024.1329305. eCollection 2024.
2
Navigating the decision landscape: understanding interstitial cystitis/bladder pain syndrome patients' motivations and medical support needs for fecal microbiota transplantation: a qualitative research.探索决策情境:了解间质性膀胱炎/膀胱疼痛综合征患者对粪便微生物群移植的动机和医疗支持需求:一项定性研究
BMC Complement Med Ther. 2025 Jul 16;25(1):268. doi: 10.1186/s12906-025-04999-4.
3
Exploring the Efficacy of Vessilen in Treating Bladder Pain Syndrome/Interstitial Cystitis: A Prospective Study.

本文引用的文献

1
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.阿米替林对治疗初发的间质性膀胱炎/膀胱疼痛综合征患者症状的影响。
J Urol. 2010 May;183(5):1853-8. doi: 10.1016/j.juro.2009.12.106. Epub 2010 Mar 29.
2
Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association.紧跟前沿:证据报告与分级的综述与分析;美国泌尿外科学会的建议
BJU Int. 2009 Aug;104(3):294-7. doi: 10.1111/j.1464-410X.2009.08729.x.
3
Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot.
探索Vessilen治疗膀胱疼痛综合征/间质性膀胱炎的疗效:一项前瞻性研究。
Healthcare (Basel). 2025 Jun 4;13(11):1340. doi: 10.3390/healthcare13111340.
4
S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome.S100A9作为实验性自身免疫性膀胱炎和间质性膀胱炎/膀胱疼痛综合征的潜在新靶点。
Biomark Res. 2025 May 9;13(1):72. doi: 10.1186/s40364-025-00763-5.
5
Exploring the causal role of pathogen-derived antibodies in major urinary and kidney diseases: Insights from generalized summary data-based Mendelian randomization.探索病原体衍生抗体在主要泌尿系统和肾脏疾病中的因果作用:基于广义汇总数据的孟德尔随机化研究的见解
Virulence. 2025 Dec;16(1):2473631. doi: 10.1080/21505594.2025.2473631. Epub 2025 Mar 11.
6
Exploring the anti-inflammatory effects of phytochemicals in attenuating interstitial cystitis-a literature review.探索植物化学物质在减轻间质性膀胱炎中的抗炎作用——文献综述
Front Pharmacol. 2025 Feb 5;16:1483548. doi: 10.3389/fphar.2025.1483548. eCollection 2025.
7
IC/BPS is not associated with bladder cancer: a nationwide propensity score matched cohort study in Taiwan.间质性膀胱炎/膀胱疼痛综合征与膀胱癌无关:台湾一项全国性倾向评分匹配队列研究
World J Urol. 2025 Feb 14;43(1):123. doi: 10.1007/s00345-025-05501-y.
8
Exploring the therapeutic potential of PACAP in Hunner-type Interstitial Cystitis.探索垂体腺苷酸环化酶激活肽在Hunner型间质性膀胱炎中的治疗潜力。
World J Urol. 2025 Jan 4;43(1):60. doi: 10.1007/s00345-024-05429-9.
9
Chronic Primary Pelvic Pain Syndromes in Women: A Comprehensive Review.女性慢性原发性盆腔疼痛综合征:综述
Cureus. 2024 Dec 1;16(12):e74918. doi: 10.7759/cureus.74918. eCollection 2024 Dec.
10
A Systematic Review of the Prevalence of Overactive Bladder in Women with Non-Urinary Tract Endometriosis and the Effect of Endometriosis Surgery on Symptoms of Overactive Bladder.非尿路子宫内膜异位症女性膀胱过度活动症患病率及子宫内膜异位症手术对膀胱过度活动症症状影响的系统评价
Int Urogynecol J. 2025 Apr;36(4):741-748. doi: 10.1007/s00192-024-06018-5. Epub 2024 Dec 30.
间质性膀胱炎/膀胱疼痛综合征/疼痛性膀胱综合征国际共识现状:2008年概况
Neurourol Urodyn. 2009;28(4):274-86. doi: 10.1002/nau.20687.
4
Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women.女性间质性膀胱炎/膀胱疼痛综合征疼痛的循证标准
Urology. 2008 Mar;71(3):444-8. doi: 10.1016/j.urology.2007.10.062.
5
Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study.间质性膀胱炎女性的引导式意象疗法:一项前瞻性随机对照试验研究结果
J Altern Complement Med. 2008 Jan-Feb;14(1):53-60. doi: 10.1089/acm.2007.7070.
6
Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative.膀胱疼痛综合征/间质性膀胱炎患者重建手术的长期结果:分型至关重要。
Urology. 2007 Oct;70(4):638-42. doi: 10.1016/j.urology.2007.05.028.
7
Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome.症状出现与就医之间的间隔时间短作为间质性膀胱炎/膀胱疼痛综合征快速起病的一个指标。
BJU Int. 2007 Sep;100(3):599-602; discussion 602. doi: 10.1111/j.1464-410X.2007.06989.x. Epub 2007 Jun 2.
8
Effect of comestibles on symptoms of interstitial cystitis.食物对间质性膀胱炎症状的影响。
J Urol. 2007 Jul;178(1):145-52. doi: 10.1016/j.juro.2007.03.020. Epub 2007 May 11.
9
Possible application of Raman microspectroscopy to verify the interstitial cystitis diagnosis after potassium sensitivity test: phenylalanine or tryptophan as a biomarker.拉曼显微光谱法在钾敏感性试验后用于验证间质性膀胱炎诊断的可能应用:苯丙氨酸或色氨酸作为生物标志物。
Dis Markers. 2007;23(3):147-52. doi: 10.1155/2007/705630.
10
Assessing urgency in interstitial cystitis/painful bladder syndrome.评估间质性膀胱炎/膀胱疼痛综合征的紧迫性。
Urology. 2007 Feb;69(2):210-4. doi: 10.1016/j.urology.2006.09.053. Epub 2007 Jan 31.